SCOPUS 정보 검색 플랫폼

American Journal of Hypertension

Volumn 22, Issue 12, 2009, Pages 1234-

Aldosterone and hypertension in African Americans

(2) Ku, Elaine a Campese, Vito M a

a UNIVERSITY OF SOUTHERN CALIFORNIA (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ALDOSTERONE ANTAGONIST; AMILORIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; POTASSIUM; SPIRONOLACTONE;

AFRICAN AMERICAN; ALDOSTERONE BLOOD LEVEL; BODY MASS; HUMAN; HYPERALDOSTERONISM; HYPERTENSION; NOTE; OBESITY; PATHOGENESIS; POTASSIUM INTAKE; POTASSIUM URINE LEVEL; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

AFRICAN AMERICANS; ALDOSTERONE; HUMANS; HYPERTENSION; RENIN;

EID: 70449838825 PISSN: 08957061 EISSN: None Source Type: Journal
DOI: 10.1038/ajh.2009.174 Document Type: Note

Times cited : (5)

References (5)

1
- 70450225065
- Aldosterone contributes to blood pressure variance and to likelihood of hypertension in normal-weight and overweight African Americans
- Kidambi S, Kotchen JM, Krishnaswami S, Grim CE, Kotchen TA. Aldosterone contributes to blood pressure variance and to likelihood of hypertension in normal-weight and overweight African Americans. Am J Hypertens 2009; 22:1303-1308.
- (2009) Am J Hypertens , vol.22 , pp. 1303-1308
- Kidambi, S.¹ Kotchen, J.M.² Krishnaswami, S.³ Grim, C.E.⁴ Kotchen, T.A.⁵

2
- 0037145856
- African American Study of Kidney Disease and Hypertension Study Group Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: Results from the AASK trial
- Wright JT Jr, Bakris G, Greene T, Agodoa LY, Appel LJ, Charleston J, Cheek D, Douglas-Baltimore JG, Gassman J, Glassock R, Hebert L, Jamerson K, Lewis J, Phillips RA, Toto RD, Middleton J P, Rostand SG; African American Study of Kidney Disease and Hypertension Study Group. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA 2002; 288:2421-2431.
- (2002) JAMA , vol.288 , pp. 2421-2431
- Wright Jr., J.T.¹ Bakris, G.² Greene, T.³ Agodoa, L.Y.⁴ Appel, L.J.⁵ Charleston, J.⁶ Cheek, D.⁷ Douglas-Baltimore, J.G.⁸ Gassman, J.⁹ Glassock, R.¹⁰ Hebert, L.¹¹ Jamerson, K.¹² Lewis, J.¹³ Phillips, R.A.¹⁴ Toto, R.D.¹⁵ Middleton, J.P.¹⁶ Rostand, S.G.¹⁷

3
- 25444446626
- Improvement in blood pressure with inhibition of the epithelial sodium channel in blacks with hypertension
- Saha C, Eckert GJ, Ambrosius WT, Chun T Y, Wagner MA, Zhao Q, Pratt JH. Improvement in blood pressure with inhibition of the epithelial sodium channel in blacks with hypertension. Hypertension 2005; 46:481-487.
- (2005) Hypertension , vol.46 , pp. 481-487
- Saha, C.¹ Eckert, G.J.² Ambrosius, W.T.³ Chun, T.Y.⁴ Wagner, M.A.⁵ Zhao, Q.⁶ Pratt, J.H.⁷

4
- 1642501689
- Urinary potassium excretion and sodium sensitivity in blacks
- Aviv A, Hollenberg NK, Weder A. Urinary potassium excretion and sodium sensitivity in blacks. Hypertension 2004; 43:707-713.
- (2004) Hypertension , vol.43 , pp. 707-713
- Aviv, A.¹ Hollenberg, N.K.² Weder, A.³

5
- 20144369497
- Hyperaldosteronism and hypertension: Ethnic differences
- Grim CE, Cowley AW Jr, Hamet P, Gaudet D, Kaldunski ML, Kotchen JM, Krishnaswami S, Pausova Z, Roman R, Tremblay J, Kotchen TA. Hyperaldosteronism and hypertension: ethnic differences. Hypertension 2005; 45:766-772.
- (2005) Hypertension , vol.45 , pp. 766-772
- Grim, C.E.¹ Cowley Jr., A.W.² Hamet, P.³ Gaudet, D.⁴ Kaldunski, M.L.⁵ Kotchen, J.M.⁶ Krishnaswami, S.⁷ Pausova, Z.⁸ Roman, R.⁹ Tremblay, J.¹⁰ Kotchen, T.A.¹¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.